Evidence map›Paper›PMID 40715955›Full record

ArticleJournal of general internal medicine2025

A Qualitative Evaluation of Factors Influencing the Lung Cancer Screening Program Navigator Role.

Lucy B Spalluto, Kemberlee Bonnet, David Schlundt, Carolyn M Audet, Claudia I Henschke, David F Yankelevitz, Sally J York, Fred Hendler, Robert S Dittus, Drew Moghanaki and 2 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of general internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lucy B SpallutoGeriatric Research Educational and Clinical Center (GRECC) and the VETWISE-LHS Center of Innovation, VA Tennessee Valley Healthcare System, Nashville, TN, USA. lucy.b.spalluto@vumc.org.ORCID 0000-0002-9821-3498
Kemberlee BonnetDepartment of Psychology, Vanderbilt University, Nashville, TN, USA.
David SchlundtDepartment of Psychology, Vanderbilt University, Nashville, TN, USA.
Carolyn M AudetDepartment of Health Policy, Vanderbilt University Medical Center, Nashville, TN, USA.
Claudia I HenschkeDepartment of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
David F YankelevitzDepartment of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Sally J YorkMedicine Service, VA Tennessee Valley Healthcare System, Nashville, TN, USA.
Fred HendlerMedicine Service, Robley Rex VA Medical Center, Louisville, KY, USA.
Robert S DittusGeriatric Research Educational and Clinical Center (GRECC) and the VETWISE-LHS Center of Innovation, VA Tennessee Valley Healthcare System, Nashville, TN, USA.
Drew MoghanakiRadiation Oncology Service, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
Christianne L RoumieGeriatric Research Educational and Clinical Center (GRECC) and the VETWISE-LHS Center of Innovation, VA Tennessee Valley Healthcare System, Nashville, TN, USA.
Jennifer A LewisGeriatric Research Educational and Clinical Center (GRECC) and the VETWISE-LHS Center of Innovation, VA Tennessee Valley Healthcare System, Nashville, TN, USA.

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
Vanderbilt Scholars in T4 Translational Research (V-STTaR) ProgramK12HL137943 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KRIPALANI, SUNIL, ROUMIE, CHRISTIANNE L. · 2017 to 2021
$2.9M
Clinical Science Research and Development CIN 24-128Conquer Cancer Foundation 2021YIA-9865677411CSRD VA I01 CX002686LUNGevity Foundation 2021-08NCI NIH HHS CA68485NCI NIH HHS P30 CA068485NHLBI NIH HHS K12 HL137943NHLBI NIH HHS K12HL137943
6 · The paper itself

Abstract

backgroundLung cancer screening program navigators improve adherence and patient experience. However, little is known about how navigators improve program outcomes.

objectiveThe aim of this qualitative study was to explore factors influencing the lung cancer screening program navigator role.

designFrom December 2020 to September 2021, we conducted a cross-sectional qualitative study of in-depth interviews in the Veterans Health Administration.

participantsWe interviewed a national sample of healthcare team members involved in lung cancer screening at 10 Veterans Affairs Medical Centers. APPROACH: We performed interviews to elicit data on lung cancer screening team and organizational characteristics, barriers to and facilitators of lung cancer screening, and factors influencing the navigator role. We utilized an iterative inductive-deductive approach for qualitative analysis based on the health systems science framework and relational coordination theory.

participantsWe conducted 30 interviews (participation rate = 56%). The 30 participants were predominantly physicians (47%), in primary care (33%), and with 1-10 years of experience in current role (37%). KEY

resultsParticipants indicated that both structural and relational factors influence the lung cancer screening program navigator role. Specifically, organizational support to strengthen the navigator's ability to function as a boundary spanner emerged as a key factor that can influence program outcomes such as efficient enrollment practices and program growth.

conclusionsHealthcare team members involved in lung cancer screening indicated that navigators play an important role in impacting lung cancer screening programs. As lung cancer screening programs continue to evolve and expand, developing organizational structure and relational coordination to support navigators can positively impact program outcomes.

Indexed as

Early Detection of CancerLung NeoplasmsPatient NavigationAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedQualitative ResearchUnited StatesUnited States Department of Veterans Affairslow-dose CTlung cancernavigatorscreening

Identifiers

PMID40715955
PMCPMC12508303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.